Sarcoidosis

Dermatologic Clinics

Volumn 20, Issue 3, 2002, Pages 435-447

  Giuffrida, T J ^a   Kerdel, Francisco A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; HUMAN; PATHOLOGY; PROGNOSIS; REVIEW; SARCOIDOSIS; SKIN DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; GRANULOMATOUS INFLAMMATION; HEREDITY; INCIDENCE; LYMPHADENOPATHY; MORTALITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SPLENOMEGALY; STEROID THERAPY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; SARCOIDOSIS; SKIN DISEASES; HUMAN;

ALLOPURINOL; CHLOROQUINE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; ISOTRETINOIN; MELATONIN; METHOTREXATE; MINOCYCLINE; PROSPIDIUM CHLORIDE; STEROID; THALIDOMIDE; TRANILAST;

EID: 0036323487     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00010-4     Document Type: Review

References (176)

1. Sarcoidosis
2. Sarcoidosis
3. Sarcoidosis
4. Sarcoidosis
5. Sarcoidosis of the skin
6. Cutaneous involvement in sarcoidosis: Relationship to systemic disease
7. Cutaneous sarcoidosis in Caucasians
8. Erythema nodosum: A presenting sign of early onset sarcoidosis
9. Clinical factors predicting persistence of activity in sarcoidosis: A multivariate analysis of 193 cases
10. Prognostic factors predicting the outcome of sarcoidosis: An analysis of 818 patients
11. Sarcoidosis: An updated review
12. Cutaneous sarcoidosis: Definitions and types of lesions
13. A clinicopathologic approach to granulomatous dermatoses
14. Sarcoidosis presenting as a scarring alopecia: Report of a rare cutaneous manifestation of systemic sarcoidosis
15. Statement of sarcoidosis: Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS board of directors and by the ERS executive committee
16. Sarcoidosis of upper respiratory tract in patients with nasal rim lesions: A pilot study
17. Granulomatous disorders of the oral mucosa
18. Laryngeal sarcoidosis and candidiasis
19. Sarcoid ranula: Its association with wide-spread sarcoidosis
20. Oral sarcoidosis with tongue involvement
21. Sarcoidosis
22. Panniculitis: Part II: Mostly lobular panniculitis
23. Reappearance of quiescent scars: Sarcoidosis
24. Acquired ichthyosiform erythroderma and sarcoidosis
25. Ulcerative sarcoidosis: Case report and review of literature
26. Generalized atrophic sarcoidosis with ulcerations
27. Ichthyosiform sarcoidosis
28. Sarcoidosis presenting as cutaneous hypopigmentation
29. Faint erythema: Another manifestation of cutaneous sarcoidosis?
30. Unilateral lower extremity edema caused by infiltrative sarcoidosis
31. Nodular lesions on fingertips
32. Sarcoidosis of the vulva: A rare cutaneous manifestation
33. Sarcoidosis of the penis
34. Multiple indurated papules on the penis and scrotum
35. Granulomatous chelitis in two children with sarcoidosis
36. Sarcoidosis presenting as erythema annulare centrifugum
37. Annular elastolytic sarcoidosis of the face
38. Sarcoidosis presenting as palmar erythema
39. Overlap of sarcoidosis and rosacea
40. Morpheaform sarcoidosis: Report of three cases
41. Umbilicated papular sarcoidosis
42. Sarcoidosis of the scalp: A case series and review of the literature J Am Acad Dermatol
43. Onycholysis in sarcoidosis: A previously undescribed association
44. Subungual hyperkeratosis due to sarcoidosis
45. Histopathology of nail sarcoidosis
46. Sarcoidosis: Nail dystrophy without underlying bone changes
47. Cutaneous manifestations of sarcoidosis: Relationships to other organ system involvement, abnormal laboratory measurements, and disease course
48. Previously undiagnosed sarcoidosis in a patient presenting with leonine facies and complete heart block
49. The clinical management of sarcoidosis: A 50-year experience at the Johns Hopkins Hospital
50. Spectrum of sarcoidosis involving the eye and brain
51. Spleenomegaly in sarcoidosis: A report of 16 cases
52. Vitamin D, calcium, and sarcoidosis
53. Increased calcium intake does not supress circulating 1,25-dihdroxyvitamin Din normocalcemic patients with sarcoidosis
54. Biliary tract obstruction due to sarcoidosis
55. Racial difference in cardiac sarcoidosis incidence observed at autopsy
56. Thallium 201 scintigraphy in the diagnosis and management of myocardial sarcoidosis
57. Musculoskeletal involvement in sarcoidosis
58. Muscular sarcoidosis
59. Sarcoidosis involving skeletal muscle: Imaging findings and relative value of imaging procedures
60. Sarcoidosis presenting as a tumorlike muscular lesion: Case report and review of the literature
61. Acute sarcoid arthritis: Occurrence, seasonal onset, clinical features and outcome
62. Tenosynovitis as initial diagnosis of sarcoidosis: Case report
63. Neurosarcoidosis: Signs, course and treatment in 35 confirmed cases
64. Diagnosis and management of neurological sarcoidosis
65. Neurosarcoidosis: A personal prospective based on the study of 37 patients
66. A comparison of sarcoidosis and Behcet's disease
67. Sudden hearing loss as the initial manifestation of neurosarcoidosis
68. Transient focal neurological deficit in sarcoidosis
69. The diagnosis and treatment of neurosarcoidosis
70. Nephrolithiasis as a presenting feature of chronic sarcoidosis
71. Diagnosis and management of urethral sarcoidosis
72. Sarcoidosis presenting as a bilateral hydronephrosis
73. Gastric sarcoidosis
74. A case of acute sarcoidosis
75. Acute pancreatitis and sarcoidosis: A case report and review of the literature
76. Sarcoidosis manifesting as acute appendicitis: Report of a case
77. Sarcoidosis resulting in duodenal obstruction in an adolescent
78. Intra-scrotal sasrcoidosis: Case reports and review
79. Sarcoidosis of the breast: Mammographic, ultrasound, and MR findings
80. Sarcoidosis presenting as bilateral testicular masses
81. Endometrial sarcoidosis as a cause of postmenopausal bleeding: A case report
82. Early onset sarcoidosis masquerading as juvenile rheumatoid arthritis
83. Childhood sarcoidosis
84. Sarcoidosis in children
85. Childhood sarcoidosis
86. Blau syndrome of granulomatous arthritis, iritis, and skin rash: A new family and review of the literature
87. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16
88. Enigmas in sarcoidosis
89. Sarcoidosis
90. Global epidemiology of sarcoidosis: What story do prevalence and incidence tell us?
91. Epidemiology of sarcoidosis
92. Incidence of clinically identified sarcoidosis in a northwest United States population
93. T-cell receptor variable region gene usage by CD4+ and CD8- Tcells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients
94. Update on sarcoidosis
95. The riddle of sarcoidosis: Have novel techniques brought any new insights as to the causative agent?
96. Multiple benign sarcoid of the skin
97. Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis
98. An assessment of peripheral immunity in patients with sarcoidosis using measurement of serum vitamin D3, cytokines, and soluble CD 23
99. Circulating adhesion molecules in sarcoidosis
100. Sarcoidosis news: Immunologic frontiers for new immunosuppressive strategies
101. Heterogeneity of familial risk in sarcoidosis
102. Epidemiology, demographics and genetics of sarcoidosis
103. The sarcoidosis map: A joint survey of clinical and immunogenetic findings in two European countries
104. HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP
105. Deletion polymorphism in angiotensin I converting enzyme (ACE) genes a genetic risk factor for sarcoidosis
106. HLA-DPB polymorphisms: Flu 69 association with sarcoidosis
107. Orosomucoid and haptoglovin types in patients with sarcoidosis
108. Tumor necrosis factor-α promoter polymorphism in erythema nodosum
109. Presence of mycobacterial DNA in sarcoidosis
110. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis
111. Detection of mycobacterial DNA in the skin
112. Mycobacteria and sarcoidosis: An overview and summary of recent molecular biological data
113. Mycobacteria and sarcoidosis: BCG ineffective against sarcoidosis
114. Sarcoidosis mythology
115. Sarcoidosis: Part 8: Granulomatous diseases of unproved etiology
116. Mycobacteria and sarcoidosis
117. Seasonal clustering of sarcoidosis presenting with erythema nodosum
118. Association between sarcoidosis and lymphoma revisited
119. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C
120. Sarcoidosis in interferon-alpha therapy
121. Sarcoidosis following beta-interferon therapy for multiple myeloma
122. Generalized ulcerative sarcoidosis induced by therapy with the flashlamp-pumped pulsed dye laser
123. Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis
124. Sarcoidosis
125. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis
126. Preschool sarcoidosis mimicking juvenile rheumatoid arthritis: The significance of gallium scintigraphy and skin biopsy in the differential diagnosis
127. The panda sign
128. Extensive cutaneous sarcoidosis Ga-67 imaging
129. Detection of extrathoracic manifestations in sarcoidosis with somatostatin analogue scintigraphy
130. Technetium-99-tetrofosmin uptake in sarcoidosis stage I
131. Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis?
132. Selection of oligoclonal V beta specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis
133. Sarcoidosis: A clinical overview
134. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of IIL-2R
135. Sarcoidosis: Immunopathogenetic concepts and their clinical application
136. Elevation of plasma-soluble tumor necrosis factor receptors (TNF-R) in sarcoidosis
137. Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis
138. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: Correlation with the clinical parameters
139. Serum type I and type III procollagen peptide levels in sarcoidosis
140. CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferongamma
141. Circulating gamma delta-T-cell-receptor-positive lymphocytes in sarcoidosis
142. Circulating soluble intercellular adhesion molecule-1(sICAM-1) in patients with sarcoidosis
143. Increase of serum copper concentration in Lofgren syndrome
144. Lupus pernio: Successful treatment with a potent topical corticosteroid
145. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing
146. Treatment of cutaneous sarcoidosis using phonophoresis
147. Cutaneous sarcoidosis: Diagnosis and treatment
148. Intralesional chloroquine for the treatment of cutaneous sarcoidosis Int J Dermatol
149. The successful treatment of lupus pernio with the flashlamp pulsed dye laser
150. CO2 laser excision of lupus pernio of the face
151. Treatment of cutaneous sarcoidosis with chloroquine
152. Prolonged use of methotrexate for sarcoidosis
153. Cutaneous sarcoidosis: Prognosis and treatment
154. Alternatives to corticosteroids in the treatment of sarcoidosis
155. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas
156. Weekly lowdose methotrexate therapy for cutaneous sarcoidosis
157. A case of cutaneous acral sarcoidosis with response to allopurinol
158. Allopurinol: A therapeutic alternative for disseminated cutaneous sarcoidosis
159. Treatment of subcutaneous sarcoidosis with allopurinol
160. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide
161. Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: A case report
162. Cutaneous sarcoidosis successfully treated with low doses of thalidomide
163. Cutaneous sarcoidosis: Complete remission after oral isotretinoin therapy
164. Successful ultraviolet A1 treatment of cutaneous sarcoidosis
165. Treatment of cutaneous sarcoidosis with tranilast
166. Melatonin for treatment of chronic refractory sarcoidosis
167. Cutaneous sarcoidosis
168. The use of tetracyclines for the treatment of sarcoidosis
169. Steroid-sparing alternative treatments for sarcoidosis
170. Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
171. Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung
172. Infliximab for refractory sarcoidosis
173. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy
174. Causes of death in patients with sarcoidosis: A morphologic study of 38 autopsies with clinicopathologic correlations
175. Cardiac sarcoidosis: Diagnostic, prognostic, and therapeutic considerations
176. Sarcoidosis mortality in the United States 1979-1991: An analysis of multiple-cause mortality data